Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy. (Q40208015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tony Mok

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

13

Paul K S Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Frankie K F Mo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Stephen L Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Nancy W Y Leung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Pun Hui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wai-Yip Lam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kowk C Lam

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wing M Ho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jane Koh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Julian W Tang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Anthony T Chan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1382-1389

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539025%20AND%20SRC:MED&resulttype=core&format=json

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States

31 December 2019

cites work

1 reference

7 January 2021

Primary liver cancers in Japan

1 reference

7 January 2021

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients

1 reference

7 January 2021

An autopsy study of hepatocellular carcinoma in hong Kong

1 reference

7 January 2021

Hepatitis B virus infection in Chinese families in Hong Kong.

1 reference

7 January 2021

Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients

1 reference

7 January 2021

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

1 reference

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

7 January 2021

Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode

1 reference

7 January 2021

Microwave coagulation therapy for hepatocellular carcinoma.

1 reference

7 January 2021

Cryosurgical ablation of hepatic tumors

1 reference

7 January 2021

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

1 reference

7 January 2021

Hepatocellular carcinoma: is current therapy really altering outcome?

1 reference

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

7 January 2021

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

7 January 2021

Hepatocellular carcinoma in Central Europe: prognostic features and survival

1 reference

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

7 January 2021

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

7 January 2021

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

7 January 2021

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

7 January 2021

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants

1 reference

7 January 2021

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

1 reference

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

7 January 2021

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

7 January 2021

HBV induced carcinogenesis

1 reference

7 January 2021

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

7 January 2021

Immune pathogenesis of hepatocellular carcinoma.

1 reference

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

7 January 2021

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

1 reference

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

7 January 2021

Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers

1 reference

7 January 2021

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

7 January 2021

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

7 January 2021

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

7 January 2021

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

1 reference

7 January 2021

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

1 reference

7 January 2021

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

1 reference

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

7 January 2021

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

7 January 2021

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

1 reference

7 January 2021

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

7 January 2021

Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC.

1 reference

7 January 2021

Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma

1 reference

7 January 2021

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

1 reference

7 January 2021

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

1 reference

7 January 2021

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

1 reference

7 January 2021

Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin

1 reference

7 January 2021

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

1 reference

7 January 2021

Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease

1 reference

7 January 2021

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

7 January 2021

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

7 January 2021

Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors

1 reference

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

7 January 2021

Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation

1 reference

7 January 2021

Management of viral hepatitis B.

1 reference

7 January 2021

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

7 January 2021

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

1 reference

7 January 2021